Q3 report, 2016

ContextVision Webcast Q3 2016 Follow the link: http://webtv.nu/contextvisionq32016 to find the Q3 webcast by CEO Anita Tollstadius ContextVision sees strong quarterly growth and breakthroughs within artificial intelligence ContextVision had a very strong Q3 with sales reaching 20,3 million SEK, which is 19% higher than Q3 2015. ContextVision’s research program within the Deep Learning technology had […]
Read More

Q2 report, 2016

ContextVision Webcast Q2 2016 Follow the link: http://webtv.nu/contextvisionq22016 to find the Q2 webcast by CEO Anita Tollstadius Global Experts Join ContextVision’s Mission to Revolutionize Digital Pathology ContextVision continues to increases its focus on deep learning, the latest artificial intelligence technology and a billion dollar market. World-renowned experts within deep learning and pathology are on board, […]
Read More

Q1 report, 2016

ContextVision Webcast Q1 2016 Follow the link: http://webtv.nu/contextvisionq12016 to find the Q1 webcast by CEO Anita Tollstadius Closing in on a game changer ContextVision is on track to become a specialist in the latest artificial intelligence technology, deep learning. Results from the first quarter were very encouraging, driven forward by the company’s R&D team of […]
Read More

Q4 report, 2015

ContextVision Webcast Q4 2015 Follow the link: http://webbtv.nu/contextvisionQ42015/ to find the Q4 webcast by CEO Anita Tollstadius The best year in our history ContextVision, the leading provider of image processing software, has delivered a record-breaking year. Reaching the highest yearly revenues ever and topped off by very good R&D-results within artificial intelligence and deep learning. […]
Read More

Q3 report, 2015

ContextVision Webcast Q3 2015 Follow the link: http://webbtv.nu/contextvisionq32015/ to find the Q3 webcast by CEO Anita Tollstadius Strong third quarter for ContextVision ContextVision AB (OSE: COV), the medical imaging software company, today announced its third quarter 2015 financial results. ContextVision achieved one of its best quarterly financial results ever, despite expanded R&D activity. ContextVision’s cash […]
Read More

Q2 report, 2015

ContextVision continues positive sales development ContextVision AB (OSE: COV), the medical imaging software company, today announced its second quarter and first half 2015 financial results. ContextVision continues its positive sales development. Revenues in the second quarter were 15 per cent higher than in the corresponding quarter last year and at par with the strong first […]
Read More

Q1 report, 2015

Sales growth and improved margins for ContextVision ContextVision AB (OSE: COV), the medical imaging software company, today announced its first quarter 2015 results. The Company’s had its best quarter in more than two years in terms of sales, and the operating margin bounced back into double digits after a relatively weak fourth quarter. ContextVision’s sales […]
Read More

Q4 report, 2014

Sales growth and increased R&D efforts ContextVision AB (OSE: COV), the medical imaging software company, today announced its fourth quarter and full year 2014 financial results. The Company saw sales growth both in the fourth quarter and for the full year, while the results were affected by increased research and development activities. For the full […]
Read More

Q3 report, 2014

ContextVision continued its stable sales development in the third quarter 2014 and saw a five per cent sales growth after the first nine months. The Company reached several milestones in broadening its technology and product offering....
Read More

Q2 report, 2014

Q2 HIGHLIGHTS Further positive sales development New major long term ultrasound customer signed All cases in long lasting legal dispute finally closed...
Read More